Lakins MA, Koers A, Giambalvo R, Munoz-Olaya J, et al. FS222, a CD137/PD-L1 tetravalent bispecific antibody exhibits low toxicity and
anti-tumor activity in colorectal cancer models. Clin Cancer Res 2020 Apr 28. pii: 1078-0432.CCR-19-2958.
PMID: 32345647